(Q42505466)

1 November 2017

Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. (English)

1 reference

1 November 2017

Guo-Xiang Liu

1

1 reference

1 November 2017

Guo-Qiang Cai

2

1 reference

1 November 2017

You-Qing Cai

3

1 reference

1 November 2017

Zhe-Jin Sheng

4

1 reference

1 November 2017

Jie Jiang

5

1 reference

1 November 2017

Zhengtong Mei

6

1 reference

1 November 2017

Zhu-Gang Wang

7

1 reference

1 November 2017

Lihe Guo

8

1 reference

1 November 2017

Jian Fei

9

1 reference

1 November 2017

language of work or name

English

0 references

publication date

13 December 2006

1 reference

1 November 2017

Neuropsychopharmacology

1 reference

1 November 2017

32

1 reference

1 November 2017

7

1 reference

1 November 2017

1531-1539

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301281

1 November 2017

0 references

cites work

The benzodiazepine binding site of GABA A receptors as a target for the development of novel anxiolytics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

A screening method for substances potentially active on learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Diazepam changes risk assessment in an anxiety/defense test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

GABA transporter heterogeneity: pharmacology and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Role of the serotonergic system in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

On the role of endogenous GABA in the forced swimming test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Mice with genetically altered GABA transporter subtype I (GAT1) expression show altered behavioral responses to ethanol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Tiagabine for the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Factors controlling measures of anxiety and responses to novelty in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Cloning and expression of a rat brain GABA transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

The mouse light-dark paradigm: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

GABAA receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Role of GABA in memory and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Animal models of depression: utility for transgenic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

The effect of two lipophilic gamma-aminobutyric acid uptake blockers in CA1 of the rat hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Diurnal variation of plasma corticosterone in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Regulation of serotonin release by GABA and excitatory amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Mutant mouse models of depression: candidate genes and current mouse lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Antiglucocorticoid treatment of depression: double-blind ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Ketoconazole administration in hypercortisolemic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Immunocytochemical localization of the GABA transporter in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

The tail suspension test: a new method for screening antidepressants in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301281

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301281

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference